Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Resmed (RSMDF) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for Resmed (RSMDF) over the last 17 years, with Q4 2025 value amounting to $2.8 million.

  • Resmed's Exchange Rate Effect rose 10960.43% to $2.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $46.2 million, marking a year-over-year increase of 30179.83%. This contributed to the annual value of $25.8 million for FY2025, which is 160081.44% up from last year.
  • Per Resmed's latest filing, its Exchange Rate Effect stood at $2.8 million for Q4 2025, which was up 10960.43% from -$71000.0 recorded in Q3 2025.
  • Resmed's Exchange Rate Effect's 5-year high stood at $35.6 million during Q2 2025, with a 5-year trough of -$28.8 million in Q4 2024.
  • For the 5-year period, Resmed's Exchange Rate Effect averaged around $303500.0, with its median value being -$140000.0 (2023).
  • As far as peak fluctuations go, Resmed's Exchange Rate Effect plummeted by 443761.06% in 2022, and later skyrocketed by 2747596.9% in 2025.
  • Quarter analysis of 5 years shows Resmed's Exchange Rate Effect stood at -$270000.0 in 2021, then soared by 4140.74% to $10.9 million in 2022, then dropped by 22.86% to $8.4 million in 2023, then crashed by 442.32% to -$28.8 million in 2024, then soared by 109.6% to $2.8 million in 2025.
  • Its last three reported values are $2.8 million in Q4 2025, -$71000.0 for Q3 2025, and $35.6 million during Q2 2025.